Mitochondrial Proteins in the Development of Parkinson’s Disease

3Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Parkinson’s disease (PD) is a multifactorial disorder whose etiology is not completely understood. Strong evidences suggest that mitochondrial impairment and altered mitochondrial disposal play a key role in the development of this pathology. Here we show this association in both genetic and sporadic forms of the disease. Moreover, we describe the mitochondrial dysfunctions in toxin-induced models of PD, thus highlighting the importance of environmental factors in the onset of this pathology. In particular, we focus our attention on mitochondrial dynamics, mitochondrial biogenesis, and mitophagy and explain how their impairment could have a negative impact on dopaminergic neurons function and survival. Lastly, we aim at clarifying the important role played by proteomics in this field of research, proteomics being a global and unbiased approach suitable to unravel alterations of the molecular pathways in multifactorial diseases.

Cite

CITATION STYLE

APA

Zilocchi, M., Fasano, M., & Alberio, T. (2019). Mitochondrial Proteins in the Development of Parkinson’s Disease. In Advances in Experimental Medicine and Biology (Vol. 1158, pp. 17–44). Springer New York LLC. https://doi.org/10.1007/978-981-13-8367-0_2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free